Glibenclamide/metformin
At a glance
- Drug Originator Merck Sante
- Drug Licenced by Bristol-Myers Squibb; Sumitomo Pharma
- Drug Class Antihyperglycaemics; Biguanides; Small molecules; Sulfonylureas
- Mechanism of Action AMP activated protein kinase stimulants; KATP channel inhibitors
- USA Patent Applicants BRISTOL MYERS SQUIBB
- USA Patents 1
- NDAs 1
- Patent Applications 23
Table of Contents

Disclaimer